(Q81440181)
Statements
CD34, CD4, and CD8 cell doses do not influence engraftment, graft-versus-host disease, or survival following myeloablative human leukocyte antigen-identical peripheral blood allografting for hematologic malignancies (English)
Robert S Negrin
Judith A Shizuru
Keith E Stockerl-Goldstein
Laura J Johnston
Thai M Cao
Ruby M Wong
Kevin Sheehan